Cargando…
Extracellular Vesicles as Potential Therapeutic Messengers in Cancer Management
SIMPLE SUMMARY: Extracellular vesicles (EVs) are vehicles of cell communication that are able to carry several types of biomolecules derived from parent cells which, in a cancer context, can represent an oncogenic behavior, delivering them to recipient cells. Additionally, EVs present advantageous f...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10215130/ https://www.ncbi.nlm.nih.gov/pubmed/37237479 http://dx.doi.org/10.3390/biology12050665 |
_version_ | 1785047989784412160 |
---|---|
author | Almeida, Cristina Teixeira, Ana Luísa Dias, Francisca Morais, Mariana Medeiros, Rui |
author_facet | Almeida, Cristina Teixeira, Ana Luísa Dias, Francisca Morais, Mariana Medeiros, Rui |
author_sort | Almeida, Cristina |
collection | PubMed |
description | SIMPLE SUMMARY: Extracellular vesicles (EVs) are vehicles of cell communication that are able to carry several types of biomolecules derived from parent cells which, in a cancer context, can represent an oncogenic behavior, delivering them to recipient cells. Additionally, EVs present advantageous features, namely biocompatibility and high stability, which make them useful as delivery systems of new potential anticancer drugs. In fact, EVs can be used for the delivery of siRNAs, miRNAs, proteins, and nanoparticles in different diseases contexts. In this review, we highlight the potential application of EVs as drug delivery systems and their clinical applications. ABSTRACT: A deeper understanding of the communication mechanisms of tumor cells in a tumor microenvironment can improve the development of new therapeutic solutions, leading to a more personalized approach. Recently, the field of extracellular vesicles (EVs) has drawn attention due to their key role in intercellular communication. EVs are nano-sized lipid bilayer vesicles that are secreted by all types of cells and can function as intermediators of intercellular communication with the ability to transfer different cargo (proteins, nucleic acids, sugar…) types among cells. This role of EVs is essential in a cancer context as it can affect tumor promotion and progression and contribute to the pre-metastatic niche establishment. Therefore, scientists from basic, translational, and clinical research areas are currently researching EVs with great expectations due to their potential to be used as clinical biomarkers, which are useful for disease diagnosis, prognosis, patient follow-up, or even as vehicles for drug delivery due to their natural carrier nature. The application of EVs presents numerous advantages as drug delivery vehicles, namely their capacity to overcome natural barriers, their inherent cell-targeting properties, and their stability in the circulation. In this review, we highlight the distinctive features of EVs, their application as efficient drug delivery systems, and their clinical applications. |
format | Online Article Text |
id | pubmed-10215130 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102151302023-05-27 Extracellular Vesicles as Potential Therapeutic Messengers in Cancer Management Almeida, Cristina Teixeira, Ana Luísa Dias, Francisca Morais, Mariana Medeiros, Rui Biology (Basel) Review SIMPLE SUMMARY: Extracellular vesicles (EVs) are vehicles of cell communication that are able to carry several types of biomolecules derived from parent cells which, in a cancer context, can represent an oncogenic behavior, delivering them to recipient cells. Additionally, EVs present advantageous features, namely biocompatibility and high stability, which make them useful as delivery systems of new potential anticancer drugs. In fact, EVs can be used for the delivery of siRNAs, miRNAs, proteins, and nanoparticles in different diseases contexts. In this review, we highlight the potential application of EVs as drug delivery systems and their clinical applications. ABSTRACT: A deeper understanding of the communication mechanisms of tumor cells in a tumor microenvironment can improve the development of new therapeutic solutions, leading to a more personalized approach. Recently, the field of extracellular vesicles (EVs) has drawn attention due to their key role in intercellular communication. EVs are nano-sized lipid bilayer vesicles that are secreted by all types of cells and can function as intermediators of intercellular communication with the ability to transfer different cargo (proteins, nucleic acids, sugar…) types among cells. This role of EVs is essential in a cancer context as it can affect tumor promotion and progression and contribute to the pre-metastatic niche establishment. Therefore, scientists from basic, translational, and clinical research areas are currently researching EVs with great expectations due to their potential to be used as clinical biomarkers, which are useful for disease diagnosis, prognosis, patient follow-up, or even as vehicles for drug delivery due to their natural carrier nature. The application of EVs presents numerous advantages as drug delivery vehicles, namely their capacity to overcome natural barriers, their inherent cell-targeting properties, and their stability in the circulation. In this review, we highlight the distinctive features of EVs, their application as efficient drug delivery systems, and their clinical applications. MDPI 2023-04-27 /pmc/articles/PMC10215130/ /pubmed/37237479 http://dx.doi.org/10.3390/biology12050665 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Almeida, Cristina Teixeira, Ana Luísa Dias, Francisca Morais, Mariana Medeiros, Rui Extracellular Vesicles as Potential Therapeutic Messengers in Cancer Management |
title | Extracellular Vesicles as Potential Therapeutic Messengers in Cancer Management |
title_full | Extracellular Vesicles as Potential Therapeutic Messengers in Cancer Management |
title_fullStr | Extracellular Vesicles as Potential Therapeutic Messengers in Cancer Management |
title_full_unstemmed | Extracellular Vesicles as Potential Therapeutic Messengers in Cancer Management |
title_short | Extracellular Vesicles as Potential Therapeutic Messengers in Cancer Management |
title_sort | extracellular vesicles as potential therapeutic messengers in cancer management |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10215130/ https://www.ncbi.nlm.nih.gov/pubmed/37237479 http://dx.doi.org/10.3390/biology12050665 |
work_keys_str_mv | AT almeidacristina extracellularvesiclesaspotentialtherapeuticmessengersincancermanagement AT teixeiraanaluisa extracellularvesiclesaspotentialtherapeuticmessengersincancermanagement AT diasfrancisca extracellularvesiclesaspotentialtherapeuticmessengersincancermanagement AT moraismariana extracellularvesiclesaspotentialtherapeuticmessengersincancermanagement AT medeirosrui extracellularvesiclesaspotentialtherapeuticmessengersincancermanagement |